J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):708-715. doi: 10.1016/j.japh.2020.01.024. Epub 2020 Feb 27.
Clinical pharmacist support for patients with type 2 diabetes mellitus (T2DM) can optimize patient outcomes and medication adherence. However, there is limited understanding of what pharmacist roles patients perceive as most helpful in T2DM management interventions. This study describes experiences of minority patients with uncontrolled T2DM in terms of perceived pharmacist helpfulness and specific roles found to be most helpful within diabetes management.
A secondary analysis of a 2-year randomized, crossover trial was conducted.
This study included 244 African American and Hispanic adults with uncontrolled T2DM who received clinical pharmacist support within a team-based model.
The patients completed a mixed-methods survey regarding their experience with the intervention that included a general helpfulness rating on a 10-point unipolar Likert scale and described the support qualitatively, including their perception of the pharmacist roles. Thematic analysis guided coding of the responses.
One hundred forty-seven (60%) patients completed the survey and had at least 1 encounter with a clinical pharmacist. Of these, 108 (74%) were African American, 39 (27%) were Hispanic, and 101 (69%) were women. The median rating of clinical pharmacist helpfulness was 10 (very helpful). Only 10 (7%) participants rated pharmacist helpfulness as 1 (not at all helpful). "Medication education and management" was the most frequently perceived supportive role of the clinical pharmacists, followed by "non-medication-related patient education," "social support," and "care coordination." Miscommunication related to scheduling was the most common reason cited for not meeting with the clinical pharmacist.
This sample of minority patients with uncontrolled T2DM recognized many roles outlined within the American Pharmacists Association Medication Therapy Management framework. Patient experiences with clinical pharmacist T2DM support are crucial for developing effective programs, maximizing patient engagement, satisfying patient needs, and ensuring that a program's intended purpose aligns with the patient perspective.
临床药师为 2 型糖尿病(T2DM)患者提供支持可以优化患者的治疗效果和药物依从性。然而,对于患者认为在 T2DM 管理干预中最有帮助的药师角色,我们的了解有限。本研究描述了控制不佳的 T2DM 少数民族患者的体验,包括他们对药师帮助程度的看法,以及在糖尿病管理中发现的最有帮助的具体角色。
对一项为期 2 年的随机交叉试验进行了二次分析。
本研究纳入了 244 名患有控制不佳的 T2DM 的非裔美国人和西班牙裔成年人,他们在基于团队的模式下接受了临床药师的支持。
147 名(60%)患者完成了关于他们对干预措施的体验的混合方法调查,该调查包括 10 分制的单极李克特量表上的总体帮助评分,并从定性上描述了支持情况,包括他们对药师角色的看法。主题分析指导了对回答的编码。
本研究中,147 名(60%)患者完成了调查,并且至少与一名临床药师进行了一次接触。其中,108 名(74%)是非洲裔美国人,39 名(27%)是西班牙裔,101 名(69%)是女性。临床药师帮助程度的中位数评分为 10(非常有帮助)。只有 10 名(7%)参与者将药师的帮助程度评为 1(完全没有帮助)。“药物教育和管理”是临床药师最常被认为的支持角色,其次是“非药物相关的患者教育”、“社会支持”和“护理协调”。未与临床药师见面的最常见原因是与预约有关的沟通不畅。
本研究中,患有控制不佳的 T2DM 的少数民族患者认识到了美国药剂师协会药物治疗管理框架中概述的许多角色。了解少数民族患者对临床药师 T2DM 支持的体验对于制定有效的计划、最大限度地提高患者参与度、满足患者需求以及确保计划的预期目的与患者观点一致至关重要。